BKIMQMUSJDOHKN-UHFFFAOYSA-N
C38H37F3N10O3 — CID 157376082
Data last refreshed: (MolForge compound catalog, from PubChem)
About BKIMQMUSJDOHKN-UHFFFAOYSA-N
BKIMQMUSJDOHKN-UHFFFAOYSA-N (PubChem CID 157376082) has the molecular formula C38H37F3N10O3 and a molecular weight of 738.78 g/mol. Its IUPAC name is 2,3-dimethyl-5-[(1-methyl-4-phenylimidazol-2-yl)methoxy]pyrazolo[1,5-a]pyrimidine;methanol;6-[(1-methyl-4-phenylimidazol-2-yl)methoxy]-2-(trifluoromethyl)imidazo[1,2-b]pyridazine.
Molecular Properties
| Compound Name | BKIMQMUSJDOHKN-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 157376082 |
| Molecular Formula | C38H37F3N10O3 |
| Molecular Weight | 738.78 g/mol |
| Exact Mass | 738.30 |
| IUPAC Name | 2,3-dimethyl-5-[(1-methyl-4-phenylimidazol-2-yl)methoxy]pyrazolo[1,5-a]pyrimidine;methanol;6-[(1-methyl-4-phenylimidazol-2-yl)methoxy]-2-(trifluoromethyl)imidazo[1,2-b]pyridazine |
| SMILES | CO.Cc1nn2ccc(OCc3nc(-c4ccccc4)cn3C)nc2c1C.Cn1cc(-c2ccccc2)nc1COc1ccc2nc(C(F)(F)F)cn2n1 |
| InChI | InChI=1S/C19H19N5O.C18H14F3N5O.CH4O/c1-13-14(2)22-24-10-9-18(21-19(13)24)25-12-17-20-16(11-23(17)3)15-7-5-4-6-8-15;1-25-9-13(12-5-3-2-4-6-12)22-16(25)11-27-17-8-7-15-23-14(18(19,20)21)10-26(15)24-17;1-2/h4-11H,12H2,1-3H3;2-10H,11H2,1H3;2H,1H3 |
| InChIKey | BKIMQMUSJDOHKN-UHFFFAOYSA-N |
| XLogP | 6.66 |
| TPSA | 134.71 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 738.78 |
| LogP ≤ 5 | 6.66 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157376082 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.